Article
Exploring circular MET RNA as a potential biomarker in tumors exhibiting high MET activity
12 May 2023
Abstract excerpt
BACKGROUND: MET-driven acquired resistance is emerging with unanticipated frequency in patients relapsing upon molecular therapy treatments. However, the determination of MET amplification remains challenging using both standard and next-generation sequencing-based methodologies. Liquid biopsy is an effective, non-invasive approach to define cancer genomic profiles, track tumor evolution over time, monitor...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
